National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.

Autor: on behalf of the Greek Haemoglobinopathies Study Group, Greek Haemoglobinopathies Study Group, Voskaridou, Ersi, Maragkos, Konstantinos, Petropoulou, Fotini, Eftihiadis, Eftihios, Klironomos, Evangelos, Koutsouka, Freideriki, Nestora, Konstantina, Tzoumari, Ioanna, Papageorgiou, Ourania, Basileiadi, Artemis, Lafiatis, Ioannis, Kattamis, Antonis, Dimitriadou, Efthimia, Kalpaka, Anastasia, Kalkana, Chrysoula, Xanthopoulidis, Georgios, Adamopoulos, Ioannis, Kaiafas, Panagiotis
Zdroj: Annals of Hematology; Jan2019, Vol. 98 Issue 1, p55-66, 12p
Abstrakt: National registries constitute an invaluable source of information and contribute to the improvement of hemoglobinopathy management. Herein, we present the second updated report of the National Registry for Haemoglobinopathies in Greece (NRHG) and critically discuss the time trends in demographics, affected births, and causes of mortality. Thirty-eight Greek hemoglobinopathy units reported data from diagnosis to the last follow-up or death by retrospectively completing an electronic form. Four thousand thirty-two patients were eligible for inclusion; more than half of them had thalassaemia major. Compared to the previous report, a reduction in the total number of all hemoglobinopathies except for hemoglobinopathy "Η" was evident. The total number of affected births was also reduced; most of them were attributable to diagnostic errors and lack of awareness. Importantly, data on iron overload are reported for the first time; although most patients had low or moderate liver iron concentration (LIC) values, a non-negligible proportion of patients had high LIC. The burden due to heart iron overload was less prominent. Cardiac- and liver-related complications are the major causes of morbidity and mortality. From 2000 to 2015, a decrease in heart-related deaths along with an increase in liver-associated fatalities was observed. The Hellenic Prevention Program along with advances in chelation regimens and iron status monitoring have resulted in improved patient outcomes. The NRHG gives insight into the effectiveness of prevention programs, the therapeutic management of hemoglobinopathies and associated outcomes. NRHG may contribute to the formulation of a roadmap for hemoglobinopathies in Europe and promote the implementation of effective public health policies. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: